Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

被引：0
|
作者：
Beitzen-Heineke, Antonia [1 ,2 ,3 ]
Ben Batalla, Isabel [1 ,2 ,3 ]
Berenbrok, Nikolaus [1 ,2 ,3 ]
Paesler, Sarina [1 ,2 ,3 ]
Gensch, Victoria [1 ,2 ,3 ]
von Amsberg, Gunhild [1 ,2 ]
Schafhausen, Philippe [1 ,2 ]
Riecken, Kristoffer [4 ]
Fischer, Thomas [5 ]
Pantel, Klaus [3 ]
Bokemeyer, Carsten [1 ,2 ]
Loges, Sonja [1 ,2 ,3 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect BMT, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect Pneumol, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Tumor Biol, Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Dept Stem Cell Transplantat, Hamburg, Germany
[5] Otto Von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3063
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
    Mesa, Ruben A.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02) : 129 - 138
  • [42] Bcr: a negative regulator of the Bcr-Abl oncoprotein
    Yun Wu
    Guozhen Ma
    Dai Lu
    Feng Lin
    Hong-Ji Xu
    Jiaxin Liu
    Ralph B Arlinghaus
    Oncogene, 1999, 18 : 4416 - 4424
  • [43] Infections and vaccination in patients with BCR::ABL1 negative myeloproliferative neoplasms
    Haberbosch, S. M.
    Mertin, F.
    Hochhaus, A.
    Heidel, F.
    Hilgendorf, I
    Crodel, C. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 108 - 108
  • [44] Recombinant Interferon Alfa in BCR/ ABL-Negative Chronic Myeloproliferative Neoplasms
    El Bitar, Sandy
    Arcasoy, Murat O.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (02) : 80 - 89
  • [45] Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
    Rabade, Nikhil
    Subramanian, P. G.
    Kodgule, Rohan
    Raval, Goutham
    Joshi, Swapnali
    Chaudhary, Shruti
    Mascarenhas, Russel
    Tembhare, Prashant
    Gujral, Sumeet
    Patkar, Nikhil
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (02) : 209 - 213
  • [46] Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms
    McFarland, Daniel C.
    Polizzi, Heather
    Mascarenhas, John
    Kremyanskaya, Marina
    Holland, Jimmie
    Hoffman, Ronald
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (12): : 1563 - 1570
  • [47] Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
    Alexandre Guy
    Johanne Poisson
    Chloe James
    Leukemia, 2021, 35 : 935 - 955
  • [48] Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort
    Elizabeth M. Kander
    Sania Raza
    Zheng Zhou
    Juehua Gao
    Anaadriana Zakarija
    Brandon J. McMahon
    Brady L. Stein
    International Journal of Hematology, 2015, 102 : 587 - 593
  • [49] Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms
    Cvetkovic, Mirjana
    Arsenovic, Isidora
    Smiljanic, Mihailo
    Sobas, Marta
    Bogdanovic, Andrija
    Lekovic, Danijela
    ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4545 - 4556
  • [50] Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort
    Kander, Elizabeth M.
    Raza, Sania
    Zhou, Zheng
    Gao, Juehua
    Zakarija, Anaadriana
    McMahon, Brandon J.
    Stein, Brady L.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (05) : 587 - 593
12345